Biomarker Predictors of Clinical Efficacy of the Anti-IgE Biologic Omalizumab in Severe Asthma in Adults: Results of the SoMOSA Study.

Published in:

American Journal of Respiratory & Critical Care Medicine, 2024, v. 210, n. 3, p. 288, doi. 10.1164/rccm.202310-1730OC

By:

• Djukanović, Ratko;
• Brinkman, Paul;
• Kolmert, Johan;
• Gomez, Cristina;
• Schofield, James;
• Brandsma, Joost;
• Shapanis, Andy;
• Skipp, Paul J. S.;
• Postle, Anthony;
• Wheelock, Craig;
• Dahlen, Sven-Erik;
• Sterk, Peter J.;
• Brown, Thomas;
• Jackson, David J.;
• Mansur, Adel;
• Pavord, Ian;
• Patel, Mitesh;
• Brightling, Christopher;
• Siddiqui, Salman;
• Bradding, Peter

Publication type:

Article